<DOC>
	<DOCNO>NCT00856583</DOCNO>
	<brief_summary>The purpose study determine whether increase all-cause mortality sertindole-treated patient comparison patient treat well-known antipsychotic ( risperidone ) use normal marketed condition treatment schizophrenia .</brief_summary>
	<brief_title>Safety Study Sertindole Versus Risperidone Under Normal Conditions Use</brief_title>
	<detailed_description>The Committee Medicinal Products Human Use ( CHMP ) request post-marketing study ascertain favourable benefit-risk profile low mortality rate see clinical study sertindole would offset high mortality rate sertindole use normal condition use . It recognise , clinical trial setting , strict patient selection monitoring could lead high compliance patient management thereby low mortality rate . Study 99824 therefore design collaboration CHMP open-label , randomise study minimum study management focus mortality general patient safety . The duration treatment period fix . No efficacy measure include .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Sertindole</mesh_term>
	<criteria>The patient sign Informed Consent Form , he/she able sign ( accord ICH GCP guideline Declaration Helsinki ) , patient 's legal representative sign Informed Consent Form The patient diagnose schizophrenia Based patient 's clinical status , new change antipsychotic treatment indicate The patient least 18 year age The patient meet criteria set national SPCs sertindole risperidone . For country sertindole market , EU SPC apply The last treatment take patient sertindole risperidone The patient never previously receive antipsychotic drug therapy The patient contraindication treatment either sertindole risperidone In addition sertindole/risperidone , treatment another antipsychotic indicate The patient homeless The patient previously include one two H. Lundbeck A/S postmarketing study , 99823 99824 The patient , opinion investigator , unlikely comply study protocol unsuitable reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>